These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9121568)

  • 1. Vaccines: a roller-coaster of hopes.
    Butler D; Maurice J; O'Brien C
    Nature; 1997 Apr; 386(6625):537-8. PubMed ID: 9121568
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines. Searching for a parasite's weak spot.
    Taubes G
    Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria vaccine trials: SPf66 and all that.
    Riley E
    Curr Opin Immunol; 1995 Oct; 7(5):612-6. PubMed ID: 8573301
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines: The take-home lesson.
    DeWeerdt S
    Nature; 2012 Apr; 484(7395):S24-5. PubMed ID: 22534529
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination using radiation- or genetically attenuated live sporozoites.
    Vaughan AM; Kappe SH
    Methods Mol Biol; 2013; 923():549-66. PubMed ID: 22990804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines.
    Sedegah M; Rogers WO; Belmonte A; Belmonte M; Banania G; Patterson N; Ferrari M; Kaslow DC; Carucci DJ; Richie TL; Doolan DL
    Vaccine; 2006 Mar; 24(11):1921-7. PubMed ID: 16298024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria: a protective paradox.
    Hoffman SL
    Nature; 2006 Dec; 444(7121):824-7. PubMed ID: 17151601
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of preerythrocytic and blood-stage malaria vaccines can be assessed in small sporozoite challenge trials in human volunteers.
    Roestenberg M; de Vlas SJ; Nieman AE; Sauerwein RW; Hermsen CC
    J Infect Dis; 2012 Aug; 206(3):319-23. PubMed ID: 22615322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The path of malaria vaccine development: challenges and perspectives.
    Arama C; Troye-Blomberg M
    J Intern Med; 2014 May; 275(5):456-66. PubMed ID: 24635625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
    Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
    Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
    Hill AV; Reece W; Gothard P; Moorthy V; Roberts M; Flanagan K; Plebanski M; Hannan C; Hu JT; Anderson R; Degano P; Schneider J; Prieur E; Sheu E; Gilbert SC
    Dev Biol (Basel); 2000; 104():171-9. PubMed ID: 11713817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination using normal live sporozoites under drug treatment.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission-blocking vaccines.
    Kaslow DC
    Chem Immunol; 2002; 80():287-307. PubMed ID: 12058646
    [No Abstract]   [Full Text] [Related]  

  • 14. Mosquito production mooted as fast track to malaria vaccine.
    Butler D
    Nature; 2003 Oct; 425(6957):437. PubMed ID: 14523404
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine.
    Luo K; Zavala F; Gordy J; Zhang H; Markham RB
    Vaccine; 2017 Apr; 35(18):2358-2364. PubMed ID: 28342669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RTS,S vaccine candidate for malaria.
    Regules JA; Cummings JF; Ockenhouse CF
    Expert Rev Vaccines; 2011 May; 10(5):589-99. PubMed ID: 21604980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. That was then but this is now: malaria research in the time of an eradication agenda.
    Kappe SH; Vaughan AM; Boddey JA; Cowman AF
    Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccine boost.
    Williams N
    Curr Biol; 2007 Dec; 17(23):R985. PubMed ID: 18181279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.